Wet Age-Related Macular Degeneration/Diabetic Macular Edema 
The MD Magazine Wet Age-Related Macular Degeneration/Diabetic Macular Edema condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.


Novel LED Sleep Mask
In most eyes, the mask reduced or resolved cysts in the OCT subfield.
Annual rate of ocular inflammatory flares fell from 200 to 49 per 100 patients.
Researchers find gap in antioxidant enzymes between AMD patients and controls.
Whether injected monthly or according to a TREX regimen, ranibizumab did not have a statistically significant effect on the development of new macular atrophy in eyes with neovascular AMD.
The FDA’s decision follows the EU’s decision last month to similarly expand the scope of the drug’s approval to include more specific causes of vision loss and blindness.
At the one-month follow-up exam, only 7% were functional non-responders, half of whom were reclassified as responders at 6-month follow-up.
During follow-up periods ranging from six months to 10 years, no increase in IOP over time was found in AMD or DME patients who received intravitreal injection of an anti-VEGF agent, no matter how many injections they received.
In the SAKURA study, a greater proportion of those in the intravitreal sirolimus treatment groups than those in the active control group met the primary endpoint, a vitreous haze score of zero at Month 5 without the use of rescue therapy.
In a new study, stroke occurred in 6.6% of the ranibizumab-treated group, compared with 7.0% of the controls matched by sociodemographic factors and comorbidities and 6.7% of the controls matched by sociodemographic factors only. These differences were not statistically significant.

Most Popular


$vacMongoViewPlus$ $vAR$